Article references (30 references )

  1. Phe T, Vlieghe E, Reid T, Harries DA, Lim K, Thai S, De Smet B, Veng CH, Kham CH, Leng S, Griensven VJ, Jacobs J. Does HIV status affect the aetiology, bacterial resistance patterns and recommended empiric antibiotic treatment in adult patients with bloodstream infection in Cambodia? Tropical Medicine and International Health. 2013;18(4):485-494. Google Scholar

  2. Berger BJ, Hussain F, Roistacher K. Bacterial infections in HIV infected patients. Infect Dis Clin N Am. 1994; 8(2): 449-465. PubMed | Google Scholar

  3. Schuster MG, Norris AH. Community-acquired Pseudomonas aeruginosa pneumonia in patients with HIV infection. AIDS. 1994; 8(10): 1437-1441. PubMed | Google Scholar

  4. Witt DJ, Craven DE, Mc Cabe, WR. Bacterial infections in adult patients with the acquired immune deficiency syndrome (AIDS) and AIDS related complex. Am J Med. 1987; 82(5): 900-906. PubMed | Google Scholar

  5. Hidron HI, Kempker R, Moann A, Rimland D. Methicillin resistant Staphylococcus aureus in HIV-infected patients. Infection and Drug Resistance. 2010; 3: 73-86. PubMed | Google Scholar

  6. Madhi AS, Petersen K, Madhi A, Khoosal M, Klugman PK. Increased disease burden and antibiotic resistance of bacteria causing severe community-acquired lower respiratory tract infections in human immunodeficiency virus Type 1-infected children. Clin Infect Dis. 2000; 31(1): 170-17. PubMed | Google Scholar

  7. Zhao X, Drlica K. Restricting the selection of antibiotic-resistant mutants: a general strategy derived from fluoroquinones studies. Clin Infect Dis. 2001; 33(3): S147-156. PubMed | Google Scholar

  8. Ewig S, Ruiz M, Torres A, Marco F, Martinez AJ, Sanchez M, Mensa J. Pneumonia acquired in the community through drug-resistant Streptococcus pneumonia. Am J Respir Crit Care Med. 1999; 159(6): 1835-1842.

  9. Meynard JL, Barbut F, Blum L, Guiget M, Chouaid C, Meyohas MC, Picard O, Petit JC, Frottier J. Risk factors for isolation of Streptococcus pneumonia with decreased susceptibility to penicillin G from patients infected with human immunodeficiency virus. Clin Infect Dis. 1996; 22(3): 437-440.

  10. Adeyemi MF, Ako-Nai AK, Adejuyigbe E, Ebhodaghe IB, Osho OP, Oyeniyi TT, Kassim OO. Molecular characterization and antibiotic resistance profiles of bacterial isolates cultured from HIV seropositive patients. Archives of Clinical Microbiology. 2015; 6(1:2): 1-11. Google Scholar

  11. Spellberg B, Guidos R, Gilbert D, Bradley J, Boucher HW, Scheld WM, Bartlett JG, Edwards J Jr. Infectious Diseases Society of America: The epidemic of antibiotic-resistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis. 2008; 46(2): 155-164. PubMed | Google Scholar

  12. Beyene G, Tsegaye W. Bacterial uropathogens in urinary tract infection and antibiotic susceptibility pattern in Jimma University specialized hospital, southwest ethiopia. Ethiop J Health Sci. 2011; 21(2): 141-6. PubMed | Google Scholar

  13. Sire JM, Nabeth P, Perrier-Gros-Claude JD, Bahsoun I, Siby T, Macondo EA,Gaye-Diallo A, Guyomard S, Seck A, Breurec S, Garin B. Antimicrobial resistance in outpatient Escherichia coli urinary isolates in Dakar, Senegal. J Infect Dev Ctries. 2007; 1(3): 263-8. Google Scholar

  14. Dromigny JA, Nabeth P, Juergens-Behr A, Perrier-Gros-Claude JD. Risk factors for antibiotic-resistant Escherichia coli isolated from community-acquired urinary tract infections in Dakar, Senegal. J Antimicrob Chemother. 2005; 56(1): 236-9. PubMed | Google Scholar

  15. Moyo SJ, Aboud S, Kasubi M, Lyamuya EF, Maselle SY. Antimicrobial resistance among producers and non-producers of extended spectrum beta-lactamases in urinary isolates at a tertiary Hospital in Tanzania. BMC Res Notes. 2010; 3: 348. PubMed | Google Scholar

  16. Dada-Adegbola HO, Muili KA. Antibiotic susceptibility pattern of urinary tract pathogens in Ibadan, Nigeria. Afr J Med Med Sci 2010; 39(3): 173-9. Google Scholar

  17. Bercion R, Mossoro-Kpinde D, Manirakiza A, Le Faou A. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui, Central African Republic. J Infect Dev Ctries 2009; 3(3): 187-90. Google Scholar

  18. Alabi AS, Frielinghaus L, Kaba H, K÷sters K, Huson MA, Kahl BC, Peters G, Grobusch MP, Issifou S, Kremsner PG, Schaumburg F. Retrospective analysis of antimicrobial resistance and bacterial spectrum of infection in Gabon, Central Africa. BMC Infect Dis. 2013; 13: 455. PubMed | Google Scholar

  19. SociÚtÚ Franšaise de Microbiologie. ComitÚ de l'antibiogramme de la sociÚtÚ franšaise de microbiologie: recommandations. 2012. Accessed on 17 November 2016.

  20. Pemba L, Charalambous S, von Gottberg A, Magadla B, Moloi V, Seabi O, Wasas A, Klugman KP, Chaisson RE, Fielding K, Churchyard GJ, Grant AD. Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. Journal of Infection. 2008; 56(3): 171-178. PubMed | Google Scholar

  21. Crewe-Brown HH, Karstaedt SA, Saunders L, Khoosal M, Nicola GJ, Wasas A and Klugman PK. Streptococcus pneumonia blood culture isolates from patients with and without Human Immunodeficiency Virus infection: alterations in penicillin susceptibilities and in serogroups or serotypes. Clin Infect Dis. 1997; 25(5): 1165-1172. PubMed | Google Scholar

  22. Írtqvist ┼, Hedlund J, Kalin M. Streptococcus pneumonia: Epidemiology, Risk Factors and Clinical Features. Semin Respir Crit Care Med. 2005; 26(6): 563-574. Google Scholar

  23. Barry AL, Pfaller MA, Fuchs PC, Packer RR. In vitro activities of 12 orally administered antimicrobial agents against four species of bacterial respiratory pathogens from US medical centers in 1992 and 1993. Antimicrob Agents Chemother. 1994; 38(10): 2419-25. PubMed | Google Scholar

  24. Doern GV, Brueggemann A, Holley HP Jr, Rauch AM. Antimicrobial resistance of Streptococcus pneumonia recovered from outpatients in the United States during the winter months of 1994 to 1995: results of a 30-center national surveillance study. Antimicrob Agents Chemother. 1996; 40(5): 1208-13. PubMed | Google Scholar

  25. Friedland IR, McCracken GHJr. Management of infections caused by antibiotic-resistant Streptococcus pneumonia. The New England Journal of Medicine. 1994; 331(6): 377-382. PubMed | Google Scholar

  26. Najafi Mosleh M, Gharibi M, Alikhani MY, Saidijam M, Vakhshiteh F. Antimicrobial susceptibility and analysis of macrolide resistance genes in Streptococcus pneumonia isolated in Hamadan. Iran J Basic Med Sci. 2014; 17(8): 595-599. PubMed | Google Scholar

  27. Karlowsky JM, Jones ME, Draghi DC, Thornsberry C, Sahm DF, Volturo GA. Prevalence and antimicrobial susceptibilities of bacteria isolated from blood cultures of hospitalized patients in the United States in 2002. Annals of Clinical Microbiology and Antimicrobials. 2004;3:7. PubMed | Google Scholar

  28. Lee BL, Kimbrough RC, Jones SR, Chaisson RE, Mills J. Infectious complications with respiratory pathogens despite ciprofloxacin therapy. N Engl J Med. 1991; 325(7): 520-1. PubMed | Google Scholar

  29. Chen DK, Mcgeer A, De Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumonia to fluoroquinolones in Canada. N Engl J Med. 1999; 341(4): 233-239. PubMed | Google Scholar

  30. Gill CJ, Sabin LL, Tham J, Hamer DH. Reconsidering empiric cotrimoxazole prophylaxis for infants exposed to HIV infection. Bulletin of the World Health Organization. 2004; 82(4): 290-297. PubMed | Google Scholar